Under-correction or full correction of myopia? A meta-analysis.
Full correction
Myopia
Nearsightedness
Under-correction
Journal
Journal of optometry
ISSN: 1989-1342
Titre abrégé: J Optom
Pays: Spain
ID NLM: 101482903
Informations de publication
Date de publication:
Historique:
received:
29
07
2019
revised:
23
03
2020
accepted:
11
04
2020
pubmed:
9
6
2020
medline:
31
8
2021
entrez:
9
6
2020
Statut:
ppublish
Résumé
To compare the effect of full-correction versus under-correction on myopia progression. A literature search was performed in PubMed, Scopus, Science Direct, Ovid, Web of Science and Cochrane library. Methodological quality assessment of the literature was evaluated according to the Critical Appraisal Skills Program. Statistical analysis was performed using Comprehensive Meta-Analysis (version 2, Biostat Inc., USA). The present meta-analysis included six studies (two randomized controlled trials [RCTs] and four non-RCTs) with 695 subjects (full-correction group, n=371; under-correction group, n=324) aged 6 to 33 years. Using cycloplegic refraction, the pooled difference in mean of myopia progression was - 0.179 D [lower and higher limits: -0.383, 0.025], which was higher but not in full correction group as compared to under correction group (p=0.085). Regarding studies using non-cycloplegic subjective refraction according to maximum plus for maximum visual acuity, the pooled difference in myopia progression was 0.128 D [lower and higher limits: -0.057, 0.312] higher in under-correction group compared with full-correction group (p=0.175). Although, difference in myopia progression did not reach significant level in either cycloplegic or non-cycloplegic refraction. Our findings suggest that, myopic eyes which are fully corrected with non-cycloplegic refraction with maximum plus sphere, are less prone to myopia progression, in comparison to those which were under corrected. However, regarding cycloplegic refraction, further studies are needed to better understand these trends.
Identifiants
pubmed: 32507615
pii: S1888-4296(20)30053-4
doi: 10.1016/j.optom.2020.04.003
pmc: PMC7752985
pii:
doi:
Substances chimiques
Mydriatics
0
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-19Informations de copyright
Copyright © 2020 Spanish General Council of Optometry. Published by Elsevier España, S.L.U. All rights reserved.
Références
Invest Ophthalmol Vis Sci. 2011 Dec 09;52(13):9362-7
pubmed: 22039230
Vision Res. 2000;40(4):371-81
pubmed: 10820617
Br J Ophthalmol. 2002 Nov;86(11):1306-11
pubmed: 12386095
Ophthalmology. 2016 Apr;123(4):697-708
pubmed: 26826749
Optom Vis Sci. 2017 Sep;94(9):856-866
pubmed: 28737608
Invest Ophthalmol Vis Sci. 2011 Apr 06;52(5):2170-4
pubmed: 21212181
Ophthalmology. 2016 Feb;123(2):391-399
pubmed: 26271839
Eye (Lond). 2016 Jun;30(6):796-804
pubmed: 26965016
Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85
pubmed: 22969068
Clin Optom (Auckl). 2018 Jul 25;10:75-86
pubmed: 30319298
Optom Vis Sci. 2016 May;93(5):497-503
pubmed: 26889820
Invest Ophthalmol Vis Sci. 2013 Apr 12;54(4):2634-44
pubmed: 23493295
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):837-46
pubmed: 16505015
J Cataract Refract Surg. 2003 Nov;29(11):2082-95
pubmed: 14670416
Optom Vis Sci. 2014 Mar;91(3):342-50
pubmed: 24445721
Adolesc Health Med Ther. 2015 Aug 13;6:133-40
pubmed: 26316834
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Surv Ophthalmol. 2011 Sep-Oct;56(5):451-60
pubmed: 21813146
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):189-195
pubmed: 27796670
Br J Ophthalmol. 2009 Sep;93(9):1181-5
pubmed: 19416935
Eye Contact Lens. 2016 Jan;42(1):16-23
pubmed: 26340385
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD004916
pubmed: 22161388
Vision Res. 2002 Oct;42(22):2555-9
pubmed: 12445849
Lancet. 2012 May 5;379(9827):1739-48
pubmed: 22559900
Strabismus. 2017 Mar;25(1):23-32
pubmed: 28166436
Optometry. 2010 Mar;81(3):153-6
pubmed: 20211445
Clin Exp Optom. 2006 Sep;89(5):315-21
pubmed: 16907670
Jpn J Ophthalmol. 2005 May-Jun;49(3):189-94
pubmed: 15944822
Ophthalmology. 2017 Dec;124(12):1857-1866
pubmed: 28669492
Ophthalmology. 2009 Mar;116(3):572-9
pubmed: 19167081
JAMA Ophthalmol. 2014 Mar;132(3):258-64
pubmed: 24435660
J Optom. 2014 Jul-Sep;7(3):147-52
pubmed: 25000870
Int J Epidemiol. 2002 Feb;31(1):88-95
pubmed: 11914301
J Ocul Pharmacol Ther. 1999 Feb;15(1):85-90
pubmed: 10048351
Psychol Methods. 2006 Jun;11(2):193-206
pubmed: 16784338
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7423-32
pubmed: 25324283
Invest Ophthalmol Vis Sci. 2012 Jul 31;53(8):5060-5
pubmed: 22729437
Optom Vis Sci. 2015 Mar;92(3):258-66
pubmed: 25611765
J Ocul Pharmacol Ther. 2006 Feb;22(1):41-6
pubmed: 16503774
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8056-62
pubmed: 21911586
Science. 1978 Sep 29;201(4362):1249-51
pubmed: 694514
Curr Eye Res. 2005 Jan;30(1):71-80
pubmed: 15875367
Acta Ophthalmol Suppl. 1985;173:85-7
pubmed: 3002114
Ophthalmic Physiol Opt. 2012 Jan;32(1):3-16
pubmed: 22150586
Optom Vis Sci. 1999 Jun;76(6):363-9
pubmed: 10416930
Eye (Lond). 2009 May;23(5):1086-9
pubmed: 18670466
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1363-8
pubmed: 26032395
Ophthalmology. 2012 Feb;119(2):347-54
pubmed: 21963266
Jpn J Ophthalmol. 2007 Jan-Feb;51(1):27-33
pubmed: 17295137
Invest Ophthalmol Vis Sci. 2002 Feb;43(2):332-9
pubmed: 11818374
Clin Exp Ophthalmol. 2013 May-Jun;41(4):329-38
pubmed: 23009037
Curr Eye Res. 2016 May;41(5):600-8
pubmed: 26237276